Intermountain Healthcare Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Intermountain Healthcare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013414
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, surgical services, behavioral health, neurosciences, and musculoskeletal and its clinical services cover dialysis, environmental, food and nutrition, clinical genetics institute, imaging, integrated care management, laboratory, nursing, pain, patient and provider publications, patient flow, patient safety, pharmacy, rehabilitation, and respiratory care. Intermountain Healthcare operates through hospitals and clinics at various locations including Burley, Smithfield, Tremonton, Logan, Providence, Brigham City, Heber City, among several others. Intermountain is headquartered in Salt Lake City, Utah, the US.

Intermountain Healthcare Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Intermountain Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 11
Ingram Medical Raises US$30 Million In Series B Venture Financing 12
Partnerships 13
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 13
Intermountain Healthcare Inc – Key Competitors 14
Intermountain Healthcare Inc – Key Employees 15
Intermountain Healthcare Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Corporate Communications 19
Nov 02, 2017: Empiric Health Announces Justin Schaper as Chief Technology Officer to Advance Evidence-Based Technology Offering 19
May 20, 2016: Dr. A. Marc Harrison Named Upcoming CEO of Intermountain Healthcare 20
Government and Public Interest 21
Nov 20, 2017: NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care 21
Jul 11, 2017: New Study Finds That Lymph Node Removal Isn’t Necessary For All Melanoma Patients 22
Jul 26, 2016: Obesity and Smoking Lead to Poorer Quality of Life for ARDS Patients Six Months After Discharge from Hospital, Study Finds 24
May 05, 2016: Study Finds Cardiac Ablation Doesn’t Reduce Atrial Fibrillation Risk For Patients With Syndrome 25
May 05, 2016: New Study Finds Patients With Atrial Fibrillation Who Are Treated With Common Blood Thinner Have Higher Rates of Dementia 26
May 05, 2016: Utah Study Finds Improvements in Warfarin Use for Atrial Fibrillation Treatment Necessary to Protect Kidney Function and Heart Health 28
Apr 02, 2016: Study Finds Elevated Levels of Newly Identified Inflammation Biomarker Offsets Benefits of Good Cholesterol 29
Product News 30
Oct 27, 2016: Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms 30
Aug 29, 2016: New Life-saving Technology at Intermountain Medical Center Improves Detection, Survival of Bladder Cancer 31
Other Significant Developments 32
May 23, 2017: Intermountain Healthcare Goes Live on the American Well Exchange 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intermountain Healthcare Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Intermountain Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 11
Ingram Medical Raises US$30 Million In Series B Venture Financing 12
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 13
Intermountain Healthcare Inc, Key Competitors 14
Intermountain Healthcare Inc, Key Employees 15
Intermountain Healthcare Inc, Other Locations 16
Intermountain Healthcare Inc, Subsidiaries 17

★海外企業調査レポート[Intermountain Healthcare Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Messer Cutting Systems GmbH:企業の戦略的SWOT分析
    Messer Cutting Systems GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Young & Co.’s Brewery, P.L.C. (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery, P.L.C. (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Reed’s, Inc.:企業の戦略・SWOT・財務情報
    Reed's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Reed's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ethiopian Electric Power Corp:電力:M&Aディール及び事業提携情報
    Summary Ethiopian Electric Power Corp (Ethiopian Electric Power), formerly The Ethiopian Electric Light and Power Authority, is an electric utility that generates, transmits and distributes electricity. The utility maintains the Interconnected System and transmits electricity from hydropower plants …
  • CorEnergy Infrastructure Trust Inc (CORR):石油・ガス:M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • Electrica SA (EL):電力:M&Aディール及び事業提携情報
    Summary Electrica SA (Electrica) is a power utility that distributes and supplies electricity. Its services include electricity supply, distribution, and trading, and power distribution networks operations and management, and design and consultation for aerial and subterranean power networks. It als …
  • Sierra Wireless Inc (SW):企業の財務・戦略的SWOT分析
    Sierra Wireless Inc (SW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Experian plc:企業の戦略・SWOT・財務情報
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Trinity Biotech Plc (TRIB):製品パイプライン分析
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Colt’s Manufacturing Company LLC:企業の戦略的SWOT分析
    Colt's Manufacturing Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • DIAsource ImmunoAssays SA:企業の製品パイプライン分析2018
    Summary DIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of BioVendor - Laboratorni Medicina as, is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The company’s products comprise immunoassays, antibodies, instruments and R …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆